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Editorial Comment
Cardiac resynchronization therapy (CRT) in young pa-
tients with congenital cardiac disease is in its infancy and is
just now beginning to be employed. The article by Moak
et al.1 points out a growing problem and, potentially, a
dilemma in this group of patients—when and how should
CRT be employed? This article raises many pertinent ques-
tions that need to be addressed. To the present time, articles
addressing the use of resynchronization therapy in children
have all been retrospective studies and for the most part in-
volved a small number of somewhat diverse patients. The
largest study to date was reported by Dubin and colleagues.2
They retrospectively reviewed the records of 103 patients at
multiple institutions, who had undergone placement of resyn-
chronization devices. Unfortunately, the centers used multi-
ple and diverse criteria for deciding when resynchronization
therapy was to be employed and multiple means of assessing
outcomes. Both articles provide an excellent beginning from
which to develop this type of therapy in children, but should
not be looked upon as providing definitive criteria for such
use.
The current major issues with the use of CRT in this pa-
tient population are similar to those posed in the adult popu-
lation and relate to indications for resynchronization therapy,
specific measures of ventricular dyssynchrony, and implant
methodology as it relates to this unique group of patients.
However, the answers may be very different. To date, indica-
tions for consideration of ventricular resynchronization have
included advanced heart failure unresponsive to medication
together with some indication for left ventricular dyssyn-
chrony with or without a wide QRS complex. Patient symp-
tomatology has been variable, ranging from being listed for
transplantation to NYHA class I.2 Use of ejection fraction
alone may not be a good indicator for CRT need. The degree
of symptoms and the likelihood of patient improvement must
be balanced by the risk of CRT placement,2 and quantitative
indicators of a declining clinical state should be used.
In all series reported to date, there has been a signifi-
cant number of nonresponders. The question then arises as to
the difference between responders and nonresponders. Du-
bin et al.2 have suggested that perhaps the nonresponders
were children who had less advanced dysfunction and higher
initial ejection fractions, and therefore failed to show much
improvement. Better patient selection criteria hopefully will
improve this.
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Measures of dyssynchrony employed are also highly vari-
able. Some authors have looked only at QRS duration,2,3
which may not be indicative of ventricular mechanical
dyssynchrony. Moak et al.1 utilized only a single m-mode
echocardiographic measure of the time from peak poste-
rior motion of the interventricular septum to the peak an-
terior motion of the left ventricular free wall. Unfortunately,
such a measure only evaluates one small area of the heart
and may or may not be representative of overall ventricular
dyssynchrony. Newer methods utilizing 2- and 3-dimensional
echocardiography and use of Doppler tissue imaging tech-
niques evaluate multiple areas of the ventricular myocardium
and may give a clearer picture of the overall degree of dyssyn-
chrony.4 Use of QRS duration alone should probably not be
used as conduction disturbances produced by chamber en-
largement, and surgical procedures may affect QRS duration
with a variable impact on ventricular dyssynchrony. Clearly,
additional investigation into the measurement and quantifi-
cation of left ventricular and, potentially right ventricular
dyssynchrony are needed in this young patient population
who may or may not have characteristics similar to the adult
population.
Implant methodology and the selection of an appropriate
left and right ventricular pacing site have not been well stud-
ied. In most series reported, placement of the left ventricular
electrode either transvenously or epicardially has for the most
part been nonspecific. Additionally, there has been little in-
vestigation at the time of implant of the effect of different
electrode sites. To improve CRT results, one must be much
more specific as to the site of left ventricular stimulation and
as recent work has shown, perhaps utilize techniques during
implant to assess the appropriateness of the electrode place-
ment, thus allowing potential movement of the electrode at
the time of implant to fully optimize the degree of resynchro-
nization.5 Finally, appropriate timing intervals including AV
delays and RV versus LV delays have also not been well stud-
ied, with little information presented in the current published
series.
While not directly discussed in the article by Moak
et al.,1 the concept of primary utilization of biventricular
pacing to prevent ventricular dyssynchrony with resultant po-
tential dysfunction arises. At the current time, there does not
appear to be any substantial evidence to support the use of this
approach. While some work addresses myocardial changes
following right ventricular-only pacing,6 extrapolation from
histologic changes to myocardial function is speculative at
best. If one confines the patient population to only those
patients with congenital complete heart block that require
pacing, only a small number will ultimately develop my-
ocardial dysfunction.7 In addition, it appears that patients
who ultimately develop ventricular dysfunction are those
who require early pacing, which would imply an early and
more severe degree of cardiac compromise leading to early
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ventricular pacing. In most series, the number of patients with
congenital complete heart block who will develop ventricu-
lar dysfunction appears to be less than 10%.7 It is potentially
possible that young patients with congenital complete heart
block and early signs of ventricular dysfunction might ben-
efit from early biventricular pacing, but this is currently also
speculative.
The use of CRT in children and young patients is an en-
tirely new treatment modality that requires a very different
approach. Its use is just beginning and it is through work such
as that presented by Moak and colleagues that our knowledge
of this therapy and intelligent selection of patients who would
benefit from it have improved. Detailed, prospective stud-
ies evaluating the relationship between ventricular dysfunc-
tion, dyssynchrony, and the use of resynchronization therapy
are clearly needed. In addition, one must be cautious when
combining patients with differing disease states into a single
group, as the answers to the questions posed may well be quite
different for diverse disease states. This is an exciting new
therapeutic area in patients with congenital heart disease. Ei-
ther inappropriate overuse or underuse of this modality would
be unfortunate, and it is hoped that well-designed prospective
clinical trials will prevent this.
References
1. Moak JP, Hasbanu K, Ramwell C, Freedenberg V, Berger JT, DiRusso
G, Callahan P: Dilated cardiomyopathy following right ventricular pac-
ing for AV block in young patients: Resolution after upgrading to
biventricular pacing system. J Cardiovasc Electrophysiol 2006;17:1068-
1071.
2. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F,
Law IH, Shannon KM, Temple J, Rosenthal E, Zimmerman FJ,
Davis A, Karpawich PP, Al Ahmad A, Vetter VL, Kertesz NJ,
Shah M, Snyder C, Stephenson E, Emmmel M, Sanatani S, Kanter R,
Batra A, Collins KK: Resynchronization therapy in pediatric and con-
genital heart disease patients. J Am Coll Cardiol 2005;46:227-283.
3. Strieper M, Karpawich P, Frias P, Gooden K, Ketchum D, Fyfe
D, Campbell R: Initial experience with cardiac resynchronization
therapy for ventricular dysfunction in young patients with surgi-
cally operated congenital heart disease. Am J Cardiol 2004;94:1352-
1354.
4. Janousek J, Tomek V, Chaloupecky V, Gebauer RA: Dilated cardiomy-
opathy associated with dual-chamber pacing in infants: Improvement
through either left ventricular cardiac resynchronization or programming
the pacemaker off allowing intrinsic normal conduction. J Cardiovasc
Electrophysiol 2004;15:470-474.
5. Gallagher P, Creighton D, Scott AA, Chuang HH, Hesselson A,
Tomassoni GF: Insertion and optimization of left ventricular pacing leads
guided by intracardiac ultrasound and velocity vector imaging. Heart
Rhythm 2006;3:S155.
6. Karpawich PP, Rabah R, Haas JE: Altered cardiac histology fol-
lowing apical right ventricular pacing in patients with congeni-
tal atrioventricular block. Pacing Clin Electrophysiol 1999;22:1372-
1377.
7. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram
N, Cohen MH, Nordenberg A, Van Hare GF, Friedman RA, Perez
M, Cecchin F, Schneider DS, Nehgme RA, Buyon JP: Congeni-
tal heart block: Development of late-onset cardiomyopathy, a pre-
viously under appreciated sequela. J Am Coll Cardiol 2001;37:238-
242.
